BEIJING and CLAREMONT, Calif., Jan. 30 /Xinhua-PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) reports that the volume of bio-enhanced feed products sold during the fourth quarter of 2007 strengthened over the third quarter of 2007 and increased 25% over the same period in the previous year.
Tianjin Kiwa Feed Co., Ltd. ("Kiwa Tianjin") is a joint-venture of Kiwa and Tianjin Challenge Feed Co., Ltd, to engage in developing, manufacturing and marketing of biologically enhanced feed for pigs, chickens, ducks, cows and fish. During 4th quarter of 2007, Kiwa Tianjin sold over 7,600 tons of bio-enhanced feed a 25% increase compared with approximately 6,100 tons during the same period of 2006.
Mr. Wei Li, the Chief Executive Officer of Kiwa stated: "the strong increase in sales shows both the huge potential of China's agricultural markets, and Kiwa's capability to continue to expand its business."
About Kiwa Bio-Tech Products Group Corporation
The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company has acquired the rights to manufacture and market AF-01 Anti-viral Aerosol Agent for use in preventing (blocking) bird-flu disease in Chinese and international markets. The Company has excellent relations with government authorities in China and has developed several innovative, high margin products, while continuing to grow through internal and external product development. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC ( http://www.sec.gov ) or visit the Company's website at http://www.kiwabiotech.com .
This press release contains information that constitutes
forward-looking statements made pursuant to the safe harbor provisions of
the Private Securities Litigation Reform Act of 1995. Any such
forward-looking statements involve risk and uncertainties that could cause
actual results to differ materially from any future results described by
the forward-looking statements. Risk factors that could contribute to such
differences include those matters more fully disclosed in the Company's
reports filed with the Securities and Exchange Commission. The
forward-looking information provided herein represents the Company's
estimates as of the date of the press release, and subsequent events and
developments may cause the Company's estimates to change. The Company
specifically disclaims any obligation to update the forward- looking
information in the future. Therefore, this forward-looking information
should not be relied upon as representing the Company's estimates of its
future financial performance as of any date subsequent to the date of this
For more information, please contact:
Kiwa Bio-Tech Products Group Corporation
|SOURCE Kiwa Bio-Tech Products Group Corporation|
Copyright©2008 PR Newswire.
All rights reserved